GENE ONLINE|News &
Opinion
Blog

PROTAC
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
Degrader-Antibody Conjugates (DACs): Targeted Protein Degradation for Therapeutics
2024-02-19
Plexium Bags $102 Million for Targeted Protein Degraders
2022-02-24
Expanding Deals and Investments Underscore Burgeoning Market of Targeted Protein Degradation
2021-10-07
Pfizer Inks Second Collaboration with Arvinas, Makes Billion-Dollar Investment on a Novel Agent for Breast Cancer Therapy
2021-07-26
New Frontiers in Therapeutics
2020-07-25Partner
LATEST
Unity Technologies Announces Unity 7 Development Roadmap at Unite Seoul
2026-07-20
Road Traffic Injuries Caused 1.34 Million Deaths and 51 Million Injuries Globally in 2023
2026-07-20
Ross Stores Expands to 2,150 Locations With 47 New Openings
2026-07-20
SRMMF Issues Formal Statement Clarifying Performance Rights Status on July 20, 2026
2026-07-20
Study Finds Collagen Peptide Supplementation May Support Bone Health in Female Runners
2026-07-20
Aspire Biopharma Signs X Games Medalist Jarryd McNeil to Promote BUZZ BOMB Line
2026-07-20
Pipistrel Introduces Voyager Aircraft With Digital Avionics for Flight Training
2026-07-20
Scroll to Top